Raymed Labs Ltd

BSE :531207 NSE :- Sector : Pharmac..
2.88
Change: 0.00(0.00%)
No Graph Available
52 week Low
2.08
52 week High
2.88
Day low
2.88
Day high
2.88
Prev Close
2.88
Open
2.88
6M return
15.20%
1Y return
17.55%
MCap(Rs. in Cr.)
1.23
Total Volume
100
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Raymed Labs
2.88
Change: 0.00 (0.00%)
1 Year return
17.55%
Risk (Std Dev)
0.06%
PE Ratio
NM
MCap( in Cr.)
1.23
Shukra Pharma.
205.60
Change: 3.05 (1.51%)
1 Year return
319.08%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Oxygenta Pharma
82.56
Change: -1.68 (-1.99%)
1 Year return
159.46%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Everest Organics
243.65
Change: -12.80 (-4.99%)
1 Year return
78.89%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.94
Change: 0.00 (0.00%)
1 Year return
19.83%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Raymed Labs reports standalone net loss of Rs 0.25 crore in the December 2024 quarter

Net Loss of Raymed Labs reported to Rs 0.25 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter ....

28 Jan 2025 07:33

Raymed Labs to declare Quarterly Result

Raymed Labs will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live News

23 Jan 2025 11:08

Raymed Labs reports standalone net loss of Rs 0.02 crore in the September 2024 quarter

Net Loss of Raymed Labs reported to Rs 0.02 crore in the quarter ended September 2024 as against net loss of Rs 0.02 crore during the previous quarter....

07 Nov 2024 07:32

Raymed Labs to announce Quarterly Result

Raymed Labs will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live News

29 Oct 2024 15:25

Raymed Labs to convene AGM

Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 September 2024.Powered by Capital Market - ....

17 Aug 2024 09:48

Raymed Labs reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Net Loss of Raymed Labs reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss of Rs 0.02 crore during the previous quarter ende....

13 Aug 2024 07:26

View More
Subscribe for our
newsletter
Open Account Now